Literature DB >> 2717438

Model confirmation of the MS-Related Symptom Checklist.

E E Gulick1.   

Abstract

Data from a 26-item self-administered MS-Related Symptom Checklist (MS-RS), designed for persons diagnosed with multiple sclerosis (MS), were factored for the purpose of (a) providing further validity for the MS-RS Checklist, (b) determining structural relationships between and within MS symptom clusters, and (c) determining conceptual similarities between symptoms contained within the MS-RS model and those associated with eight neurological functional systems. Data analyses were based on 491 MS subjects. Principal component analysis and Varimax-rotated factor analysis were used to achieve scale parsimony. The resultant 22-item scale consisting of five factors was subjected to confirmatory factor analysis to determine relationships among factors, observed variables, and residual variance within the factor model. Modification of the initial factor model resulted in the inclusion of one additional relationship between an observed variable and a second factor and six paired relations among the residual variances. The modified factor model had a satisfactory GFI of .910. Signs and symptoms contained within the five-factor solution compared favorably with signs and symptoms assigned to the neurological functional systems which are used clinically in classifying MS disease impairment.

Entities:  

Mesh:

Year:  1989        PMID: 2717438

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  9 in total

1.  The association of symptoms with health outcomes in chronically ill adults.

Authors:  Lisa M Walke; Amy L Byers; William T Gallo; Jérôme Endrass; Terri R Fried
Journal:  J Pain Symptom Manage       Date:  2007-01       Impact factor: 3.612

2.  Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis.

Authors:  Pamela Newland; Louise Flick; Hong Xian; Florian P Thomas
Journal:  Int J MS Care       Date:  2016 Jul-Aug

3.  Testing of Journal Writing for Symptom Concordance in Adults with Multiple Sclerosis.

Authors:  Pamela Newland; B Ann Bettencourt; Sarah Schares; Verna Hendricks-Ferguson
Journal:  Int J MS Care       Date:  2021-01-21

4.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

5.  The use of focus groups to characterize symptoms in persons with multiple sclerosis.

Authors:  Pamela K Newland; Florian P Thomas; Marguerite Riley; Louise H Flick; Arleen Fearing
Journal:  J Neurosci Nurs       Date:  2012-12       Impact factor: 1.230

6.  A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

Authors:  D T Wade; C A Young; K R Chaudhuri; D L W Davidson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

7.  Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist.

Authors:  Zeliha Tülek; Cansu Polat; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2016-04-26       Impact factor: 1.339

8.  Sensitivity to heat in MS patients: a factor strongly influencing symptomology--an explorative survey.

Authors:  Gullvi Flensner; Anna-Christina Ek; Olle Söderhamn; Anne-Marie Landtblom
Journal:  BMC Neurol       Date:  2011-02-25       Impact factor: 2.474

Review 9.  Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives.

Authors:  Osman Ozel; Caila B Vaughn; Svetlana P Eckert; Dejan Jakimovski; Alexis A Lizarraga; Bianca Weinstock-Guttman
Journal:  Patient Relat Outcome Meas       Date:  2019-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.